Truscreen updates FY26 guidance

Apr 28, 2026 | Latest News

28.4.26 Truscreen Group the provider of AI enabled cervical cancer screening technology confirmed unaudited revenue and earnings guidance for the March financial year. The updated FY26 revenue guidance is for unaudited product sales revenue in line with the prior guidance at approximately $2.4 million, representing an increase of 41% on FY25. Total unaudited revenue for […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Truscreen updates FY26 guidance

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here